Bliss GVS Pharma Limited announced the outcome of its Board Meeting held on December 23, 2025. The Board approved the appointment of Mr. S. N. Kamath as the Managing Director for a period of three consecutive years. This appointment is effective from the date of passing a Special Resolution by the shareholders, subject to their approval via Postal Ballot. Upon receiving shareholder approval, Mr. S. N. Kamath will hold the dual role of Managing Director & Chief Executive Officer. The Board also approved the draft Postal Ballot Notice to seek this approval. The meeting commenced at 11:47 A.M. and concluded at 1:45 P.M. Mr. Kamath, a seasoned professional, has been instrumental in the company's growth, including expanding its presence to over 60 countries and establishing manufacturing units. He is currently the Chief Executive Officer. Mr. S.N. Kamath is the father of Dr. Vibha Gagan Sharma and Mrs. Shruti Vishal Rao, both Whole-Time Directors of the Company. He is not debarred from holding the office of Director by any SEBI order.